Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2024-05-15 | OrbiMed Israel BioFund GP Limited Partnership | - | Sell | 24,344 | $0.38 | $9,279.93 | -0.2% | → |
| 2023-11-29 | Oron Assaf | Chief Business Officer | Sell | 10,914 | $0.37 | $4,071.54 | -59.2% | → |
| 2023-05-22 | Oron Assaf | Chief Business Officer | Buy | 3,192 | $0.27 | $871.74 | +41.3% | → |
| 2023-05-19 | Oron Assaf | Chief Business Officer | Buy | 7,722 | $0.28 | $2,159.26 | +643.0% | → |
| 2023-02-27 | OrbiMed Israel BioFund GP Limited Partnership | - | Buy | 348,000 | $0.25 | $85,260.00 | +12.4% | → |
| 2022-11-04 | Ugwumba Chidozie | Exit Form 4 - former 10% owner | Sell | 74,955 | $0.35 | $26,599.04 | -0.2% | → |
| 2022-10-14 | Ugwumba Chidozie | Exit Form 4 - former 10% owner | Sell | 277,247 | $0.39 | $107,246.52 | -0.4% | → |
| 2022-09-15 | Ugwumba Chidozie | Exit Form 4 - former 10% owner | Sell | 27,913 | $0.52 | $14,594.01 | -0.1% | → |